Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Idasanutlin by F. Hoffmann-La Roche for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
Idasanutlin is under clinical development by F. Hoffmann-La Roche and currently in Phase II for B-Cell Acute Lymphocytic Leukemia (B-Cell...
Idasanutlin by F. Hoffmann-La Roche for Neuroblastoma: Likelihood of Approval
Idasanutlin is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Neuroblastoma. According to GlobalData, Phase...
Idasanutlin by F. Hoffmann-La Roche for Solid Tumor: Likelihood of Approval
Idasanutlin is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Solid Tumor. According to GlobalData,...